FY2024 Earnings Estimate for Jushi Issued By Ventum Cap Mkts

Jushi Holdings Inc. (OTCMKTS:JUSHF) – Research analysts at Ventum Cap Mkts reduced their FY2024 EPS estimates for shares of Jushi in a research note issued to investors on Monday, November 11th. Ventum Cap Mkts analyst A. Semple now anticipates that the company will earn ($0.27) per share for the year, down from their previous estimate of ($0.22). Ventum Cap Mkts has a “Hold” rating on the stock. The consensus estimate for Jushi’s current full-year earnings is ($0.21) per share. Ventum Cap Mkts also issued estimates for Jushi’s Q4 2024 earnings at ($0.05) EPS, FY2025 earnings at ($0.19) EPS and FY2026 earnings at ($0.17) EPS.

Jushi (OTCMKTS:JUSHF) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.04). The company had revenue of $61.61 million for the quarter, compared to the consensus estimate of $65.53 million. Jushi had a negative net margin of 20.93% and a negative return on equity of 5,529.11%.

Jushi Price Performance

Shares of OTCMKTS:JUSHF opened at $0.45 on Thursday. Jushi has a one year low of $0.22 and a one year high of $1.09. The firm has a fifty day moving average price of $0.49 and a two-hundred day moving average price of $0.56. The company has a market cap of $87.50 million, a price-to-earnings ratio of -1.65 and a beta of -0.86.

Jushi Company Profile

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.